Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Countries

 

2021: A boom year for health care M&A

The M&A market has roared out of Covid in the first quarter according to the HBI Panel Discussion. Are multiples likely to drop and what is investor appetite?

Korian expands psychiatric platform

Pan-European care giant Korian has bought the third largest mental health platform in Spain following its re-entry to the mental health sector with its purchase of French group Inicea.

Interview: Martin Jones, CEO, Home Instead UK

This week we interview Martin Jones, the CEO of UK-based home care operator Home Instead, about the effect of COVID on the market, drivers, and the growth of the franchise model.

Which UK private hospitals earned the most from £2bn NHS block-booking?

NHS England will have spent around £2bn on buying capacity and services from the private hospital sector for COVID-19 related services in the last 12 months, according to recently-released public documents. We break out the figures to reveal which operators earned the most and how the picture changed in Q4. 

For-profit homecare may struggle to compete after French reform

Legislation in France is set to hike minimum homecare carer wages by 20% in the not-for-profit sector, with financial support from the government to do this. HBI hears low margin for-profit operators fear they will struggle to match this and retain staff.

UK assisted living sector expansion fuelled by sales – not rental

The for-profit assisted living sector is expanding rapidly in the UK, but unlike on the continent, the majority of this expansion will be through property sales rather than rentals. HBI speaks to Michael Voges, from the Associated Retirement Community Operators (ARCO), to find out more about why this approach differs from mainland Europe.

Mehilainen targets Estonia for international expansion

Finnish outpatient and occupational healthcare specialist Mehilainen has made two acquisitions in Estonia. The company says strong expansion into Estonia is a natural next step in Mehilainen’s internationalisation strategy.

Vaccines causing minimal headwinds in COVID-19 testing volumes

HBI analysis of COVID-19 testing volumes and pricing reveals how vaccine programmes and the rise of antigen tests might impact future growth for the lab groups. PCR volumes and have dropped 16% in the UK since it started vaccinating its population and one lab group is expecting a 35% to 50% drop in COVID revenue this year.

Find Us